Acro Biomedical Co Ltd Revenue Growth Rates (ACBM), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Acro Biomedical Co Ltd   (ACBM)
    Sector • Services    Industry • Movies and Entertainment
   Industry • Movies and Entertainment
   Sector • Services
 

ACBM's Revenue Growth by Quarter and Year

Acro Biomedical Co Ltd 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACBM Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.00
FY 0.00

ACBMs Annual Revenue
Acro Biomedical Co Ltd 's Revenue in the fiscal year 2025 $ 0.00 millions
Acro Biomedical Co Ltd 's Revenue in the fiscal year 2024 $ 0.00 millions
Acro Biomedical Co Ltd 's Revenue in the fiscal year 2023 $ 0.00 millions
Acro Biomedical Co Ltd 's Revenue in the fiscal year 2022 $ 0.66 millions
Acro Biomedical Co Ltd 's Revenue in the fiscal year 2021 $ 1.20 millions




ACBM Revenue first quarter 2026 Y/Y Growth Comment
Acro Biomedical Co Ltd in the first quarter 2026 recorded of $ 0.00 millions.

According to the results reported in the first quarter 2026, Acro Biomedical Co Ltd achieved the best Revenue growth in Movies and Entertainment industry. While Acro Biomedical Co Ltd ' s Revenue no change of 0% ranks overall at the positon no. in the first quarter 2026.


ACBM Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Acro Biomedical Co Ltd 's first quarter 2026 Revenue $ 0.00 millions ACBM's Income Statement
Acro Biomedical Co Ltd 's first quarter 2025 Revenue $ 0.00 millions Quarterly ACBM's Income Statement


ACBM Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to ACBM Growth rate Comparisons >> Back to ACBM Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Movies and Entertainment Industry #
Services Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Movies and Entertainment Industry #
Services Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Acro Biomedical Co Ltd 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACBM's I. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Movies and Entertainment Industry #
Services Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Movies and Entertainment Industry #
Services Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ACBM's I. Quarter Q/Q Revenue Comment


Acro Biomedical Co Ltd 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Mar 31 2026 period, Acro Biomedical Co Ltd 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Acro Biomedical Co Ltd achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Movies and Entertainment Industry #
Services Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2026 period, Acro Biomedical Co Ltd 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Acro Biomedical Co Ltd achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Movies and Entertainment Industry #
Services Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Movies and Entertainment Industry Revenue Growth Trends and Statistics
Services Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ACBM's Revenue Growth Ratio versus Movies and Entertainment Industry, Services Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Mar 31 2026 within Services SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Bgsf Inc-0.01%$ -0.010 millions
Liberty Latin America Ltd -0.06%$ -0.065 millions
The Western Union Company-0.09%$ -0.092 millions
Ryder System Inc -0.16%$ -0.160 millions
Comscore Inc -0.45%$ -0.452 millions
Rxo Inc -0.56%$ -0.558 millions
Full House Resorts Inc-0.85%$ -0.849 millions
Warner Bros Discovery Inc -0.96%$ -0.958 millions
Copper Property CTL Pass Through Trust-0.99%$ -0.992 millions
Cco Holdings Llc-1.00%$ -1.005 millions
Charter Communications Inc -1.00%$ -1.005 millions
Versant Media Group Inc -1.11%$ -1.114 millions
Carriage Services Inc -1.13%$ -1.125 millions
Park Hotels and Resorts Inc -1.27%$ -1.270 millions
The E w Scripps Company-1.43%$ -1.435 millions
Galaxy Gaming Inc -1.57%$ -1.572 millions
Proficient Auto Logistics, Inc-1.59%$ -1.593 millions
Gogo Inc -1.73%$ -1.732 millions
Gray Media Inc -1.79%$ -1.790 millions
Liveone Inc -1.91%$ -1.913 millions
Townsquare Media Inc -1.92%$ -1.919 millions
Willscot Holdings Corporation-1.95%$ -1.952 millions
Fiserv Inc -2.01%$ -2.008 millions
Boxlight Corporation-2.16%$ -2.158 millions
Tidewater Inc-2.17%$ -2.166 millions
Krispy Kreme Inc -2.17%$ -2.172 millions
Amc Global Media Inc -2.36%$ -2.360 millions
Access Newswire Inc -2.72%$ -2.721 millions
Sweetgreen Inc -2.88%$ -2.876 millions
Ibotta Inc -2.90%$ -2.899 millions


About Acro Biomedical Co Ltd Revenue Growth Rates (ACBM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Acro Biomedical Co Ltd (CIK 1622996).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001640334-26-001345
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Acro Biomedical Co Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.